Literature DB >> 25807934

Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.

Christopher P Neal1, Vaux Cairns, Michael J Jones, Muhammad M Masood, Gael R Nana, Christopher D Mann, Giuseppe Garcea, Ashley R Dennison.   

Abstract

A range of prognostic cellular indices of the systemic inflammatory response, namely the neutrophil-lymphocyte ratio (NLR), derived NLR (dNLR), platelet-lymphocyte ratio (PLR), lymphocyte-monocyte ratio (LMR), combination of platelet count and neutrophil-lymphocyte ratio (COP-NLR) and prognostic nutritional index (PNI), have been developed and found to have prognostic utility across varied malignancies. The current study is the first to examine the prognostic value of these six inflammatory scores in patients with resectable colorectal liver metastases (CRLM). Data from 302 consecutive patients undergoing surgery for resectable CRLM were evaluated. The prognostic influence of clinicopathological variables and the inflammatory scores NLR, dNLR, PLR, LMR, COP-NLR and PNI upon overall survival (OS) and cancer-specific survival (CSS) were determined by log-rank analysis and univariate and multivariate Cox regression analyses. High preoperative NLR was the only inflammatory variable independently associated with shortened OS (HR 1.769, 95 % CI 1.302-2.403, P < 0.001) or CSS (HR 1.927, 95 % CI 1.398-2.655, P < 0.001) following metastasectomy. When NLR was replaced by dNLR in analyses, high dNLR was independently associated with shortened OS (HR 1.932, 95 % CI 1.356-2.754, P < 0.001) and CSS (HR 1.807, 95 % CI 1.209-2.702, P = 0.004). The inflammatory scores PLR, LMR, COP-NLR and PNI demonstrated no independent association with either overall or cancer-specific survival in the study population. Our findings support high preoperative NLR and dNLR as independent prognostic factors for poor outcome in patients undergoing CRLM resection, with prognostic value superior to other cellular-based systemic inflammatory scores.

Entities:  

Mesh:

Year:  2015        PMID: 25807934     DOI: 10.1007/s12032-015-0590-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  47 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

Authors:  Donald C McMillan
Journal:  Cancer Treat Rev       Date:  2012-09-17       Impact factor: 12.111

3.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.

Authors:  Hiroaki Nozawa; Christopher Chiu; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

4.  Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor.

Authors:  Kyriakos Neofytou; Elizabeth C Smyth; Alexandros Giakoustidis; Aamir Z Khan; David Cunningham; Satvinder Mudan
Journal:  Med Oncol       Date:  2014-09-14       Impact factor: 3.064

5.  The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer.

Authors:  Basem Azab; Farhan Mohammad; Neeraj Shah; Steven Vonfrolio; William Lu; Shiksha Kedia; Scott W Bloom
Journal:  Cancer Biomark       Date:  2014       Impact factor: 4.388

6.  Polymorphonuclear leukocytes increase the adhesion of circulating tumor cells to microvascular endothelium.

Authors:  Miranda Ten Kate; Arend G J Aalbers; Wim Sluiter; Leo J Hofland; Pieter Sonneveld; Johannes Jeekel; Casper H J Van Eijck
Journal:  Anticancer Res       Date:  2007 Jan-Feb       Impact factor: 2.480

7.  Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.

Authors:  Veronica C Ardi; Tatyana A Kupriyanova; Elena I Deryugina; James P Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

8.  Systemic inflammatory response predicts survival following curative resection of colorectal cancer.

Authors:  D C McMillan; K Canna; C S McArdle
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

9.  Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

Authors:  Hassan Z Malik; K Rajendra Prasad; Karim J Halazun; Amir Aldoori; Ahmed Al-Mukhtar; Dhanwant Gomez; J Peter A Lodge; Giles J Toogood
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

10.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

Authors:  M J Proctor; D C McMillan; D S Morrison; C D Fletcher; P G Horgan; S J Clarke
Journal:  Br J Cancer       Date:  2012-07-24       Impact factor: 7.640

View more
  42 in total

1.  Prognostic value of thrombocytosis in patients undergoing surgery for colorectal cancer with synchronous liver metastases.

Authors:  C Pedrazzani; G Turri; G Mantovani; C Conti; R Ziello; S Conci; T Campagnaro; A Ruzzenente; A Guglielmi
Journal:  Clin Transl Oncol       Date:  2019-04-02       Impact factor: 3.405

2.  Comment on "prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases".

Authors:  David G Watt; Paul G Horgan; Donald C McMillan
Journal:  Med Oncol       Date:  2015-04-23       Impact factor: 3.064

3.  Preoperative Leucocyte-Based Inflammatory Scores in Patients with Colorectal Liver Metastases: Can We Count on Them?

Authors:  Aurélien Dupré; Robert P Jones; Rafael Diaz-Nieto; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

4.  A Low Neutrophil to Lymphocyte Ratio Before Preoperative Chemotherapy Predicts Good Outcomes After the Resection of Colorectal Liver Metastases.

Authors:  Rui Mao; Jian-Jun Zhao; Xin-Yu Bi; Ye-Fan Zhang; Zhi-Yu Li; Zhen Huang; Jian-Guo Zhou; Hong Zhao; Jian-Qiang Cai
Journal:  J Gastrointest Surg       Date:  2018-07-31       Impact factor: 3.452

5.  Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma.

Authors:  Ilaria Lucca; Michela de Martino; Sebastian L Hofbauer; Nura Zamani; Shahrokh F Shariat; Tobias Klatte
Journal:  World J Urol       Date:  2015-04-17       Impact factor: 4.226

6.  Outcome of indeterminate liver lesions on computed tomography in patients with colorectal cancer.

Authors:  E Mohamed; A Adiamah; W K Dunn; Y Higashi; I C Cameron; D Gomez
Journal:  Ann R Coll Surg Engl       Date:  2018-04-25       Impact factor: 1.891

Review 7.  Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis.

Authors:  Jingwen Zhang; Lishan Chen; Rui Zhou; Huiying Sun; Yulin Liao; Wangjun Liao
Journal:  Gastroenterol Res Pract       Date:  2016-08-09       Impact factor: 2.260

8.  Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery.

Authors:  Jose M Soliz; Ifeyinwa C Ifeanyi; Mathew H Katz; Jonathan Wilks; Juan P Cata; Thomas McHugh; Jason B Fleming; Lei Feng; Thomas Rahlfs; Morgan Bruno; Vijaya Gottumukkala
Journal:  Anesth Pain Med       Date:  2017-08-21

9.  Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.

Authors:  Xiaowei Sun; Xuechao Liu; Jianjun Liu; Shangxiang Chen; Dazhi Xu; Wei Li; Youqing Zhan; Yuanfang Li; Yingbo Chen; Zhiwei Zhou
Journal:  Chin J Cancer       Date:  2016-06-24

Review 10.  Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis.

Authors:  Haowen Tang; Bingmin Li; Aiqun Zhang; Wenping Lu; Canhong Xiang; Jiahong Dong
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.